You have printed or saved this information from, the website for the Horizon Health Network

Facebook Icon LinkedIn Icon Twitter Icon Icon Icon
Print this page

Completed Trials

ACCLAIM (A Multi-Center, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess the Effects of Vasogen's Immune Modulation Therapy (Celacade) on Mortality and Morbidity in Patients with Chronic Heart Failure)

APEX AMI (A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of Pexelizumab in Patients with Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention)

BALANCE (Treatment of Hyponatremia Based on Lixivaptan in NYHA Class III/IV Cardiac Patient Evaluation)
Principal Investigator: Dr. David Marr

CENTAURUS (Comparison of the Effects Noted in The ApoB/ApoA-I ratio Using Rosuvastatin and atorvastatin in patients with acUte coronary Syndrome)

COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation)

EARLY ACS (Early Glycoprotein 11b/111a Inhibition in Non-ST-Elevation Acute Coronary Syndrome: A Randomized, Placebo-Controlled Trial Evaluating The Clinical Benefits of Early Front-loaded Eptifibatide in the Treatment of Patients with Non-ST-Segment Elevation Acute Coronary Syndrome)

FOCUS (A placebo-controlled, double-blind, randomized, multicenter study of ramipril 5 and 10 mg capsules and insulin infusion in subjects with unstable coronary syndromes (Focus On Coronary Unstable Syndromes)

GRACE 2 (The Global Registry of Acute Coronary Events)

IMAGINE (Ischemia Management With Accupril Post Bypass Graft Via Inhibition of Converting Enzyme (IMAGINE):  An Evalauation of the Effect of 12 To Approximately 43 Months Treatment With Quinipril 40MG QD Post CABG Surgery On Ischemic Events)

OAT (Occluded Artery Trial)

PERISCOPE (A Double-Blind, Randomized Comparator-Controlled Study in Subjects with Type II Diabetes Mellitus Comparing the Effects of Pioglitazone HCl versus Glimepiride on the Rate of Progression of Coronary Atherosclerotic Disease as Measured by Intravascular Ultrasound)

PLATO(A Randomised, Double-blind, Parallel Group, Phase 3, Efficacy and Safety Study of AZD6140 Compared with Clopidogrel for Prevention of Vascular Events in Patients with Non-ST or ST Elevation Acute Coronary Syndromes (ACS)[PLATO - A Study of PLATelet inhibition and Patient Outcomes.]

ROCKET A-FIB (A Prospective, Randomized, Double-Blind, Double-Dummy, Parallel Group, Multicenter, Event-Driven, Non-Inferiority Study Comparing the Efficacy and Safety of Once-Daily Oral Rivaroxaban (BAY 59-7939) with Adjusted-Dose Oral Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Subjects with Non-Valvular Atrial Fibrillation)

TIMI 38(Comparison of CS-747 and Clopidogrel in Acute Coronary Syndrome Subjects who are to Undergo Percutaneous Coronary Intervention)

TRIDENT (A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess The Effects of Intravenous BG9928 on Body Weight in Subjects with Acute Decompensated Heart Failure and Renal Insufficiency)

VIA(A Phase 2 Randomized, Double-blind, Parallel-group, Placebo-controlled, Dose-ranging Study of the Effect of VIA-2291-01, a 5 lipoxygenase Inhibitor, on Biomarkers of Vascular Inflammation in Patients After an Acute Coronary Syndrome Event.)

ZESCA (Zyban as an Effective Smoking Cessation Aid for Patients Following an Acute Coronary Syndrome)

Facebook Icon LinkedIn Icon Twitter Icon Icon Icon
Text Size:

Helpful Links